Tetrac-Conjugated Quantum Dots for Diagnosis and Treatment of Pancreatic Cancer: An In Vitro Evaluation

2009 ◽  
Vol 9 (4) ◽  
pp. 219-223 ◽  
Author(s):  
Dhruba Bharali ◽  
Usawadee Dier ◽  
Paul Davis ◽  
Shaker Mousa
2013 ◽  
Vol 54 (suppl 1) ◽  
pp. i113-i119 ◽  
Author(s):  
R. A. El Shafie ◽  
D. Habermehl ◽  
S. Rieken ◽  
A. Mairani ◽  
L. Orschiedt ◽  
...  

2017 ◽  
Vol 70 (12) ◽  
pp. 1302 ◽  
Author(s):  
Hai-Kang Huang ◽  
Jing Yan ◽  
Pei Liu ◽  
Bi-Yun Zhao ◽  
Yi Cao ◽  
...  

A nanotheranostic system is a new system that combines both diagnosis and treatment of a malignant disease, e.g. cancer, by exploitation of the unusual properties of nano-sized particles. In this project, we have developed a novel nanotheranostic system based on quantum dots (QDs) coated with drug-loaded polymer. We first synthesized a double-group functionalized amphiphilic triblock copolymer and loaded it with the anti-tumour drug paclitaxel (PTX) and lipoic acid (LA) to obtain the prodrug mPEG-block-PCL-(graft-PTX)-block-PLA-(graft-LA) (mPEG: methoxy polyethylene glycol, PLA: poly(norbornene-lactide)s). When exposed to UV light (365 nm), the disulfide bond of LA was broken into two sulfydryls, which could in turn adhere to the surface of CdSe/ZnS QDs to form a nanotheranostic system. This novel system exhibited good controlled drug release behaviour due to the ester linkage between the drug and polymer. By using typical cancer cell lines, we showed that this nanotheranostic system is promising in cancer diagnosis and treatment in vitro.


2017 ◽  
Vol 34 (6) ◽  
pp. 582-591 ◽  
Author(s):  
Merari T. Chevalier ◽  
Mónica C. García ◽  
Daniela Gonzalez ◽  
Sandro M. Gomes-Filho ◽  
Daniela S. Bassères ◽  
...  

2015 ◽  
Vol 121 ◽  
pp. 132-139 ◽  
Author(s):  
Haixing Xu ◽  
Jingbo He ◽  
Yu Zhang ◽  
Lihong Fan ◽  
Yaqiong Zhao ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Abbey Y. Kardys ◽  
Dhruba J. Bharali ◽  
Shaker A. Mousa

We report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety such as anti-Claudin-4 (CLN4). The preferential uptake in pancreatic cancer cells, where CLN4 is overexpressed, of SiNPs when conjugated to CLN4 antibody (compared to nonconjugated SiNPs) was confirmed by confocal microscopy. SiNPs encapsulating doxorubicin had greater efficacy in MTT assays than free doxorubicin, and when conjugated to CLN4, the efficacy was dramatically increased (at 1 μM). No apparent carrier toxicity was observed when void SiNPs were used. SiNPs carrying a chemotherapeutic drug have the potential to be used as a targeted therapy for lethal cancers, such as pancreatic cancer. Also, incorporation of fluorescent probes in these SiNPs creates the possibility of their use as an imaging probe for diagnostic purposes.


Sign in / Sign up

Export Citation Format

Share Document